The St. Jude Medical Infinity™ Deep Brain Stimulation (DBS) system with directional lead technology is designed to help patients with Parkinson’s disease or essential tremor gain control of their ...

Shabbar Danish, chief, Neurosurgery, Rutgers Cancer Institute, and director of Stereotactic and Functional Neurosurgery at RWJUH, successfully implanted the device in the first patient Oct. 25 at ...

The US Food and Drug Administration (FDA) has approved a new software upgrade for Abbott's Infinity deep-brain stimulation (DBS) system used in patients with Parkinson's disease and essential tremor, ...

Abbott Laboratories (NYSE:ABT) received FDA approval to launch the Liberta RC DBS system, the world’s smallest rechargeable deep brain stimulation (DBS) device with remote programming, to treat people ...

St. Jude Medical Inc.STJ recently announced the receipt of CE Mark approval for its Infinity Deep Brain Stimulation ("DBS") System and directional DBS lead, allowing sale in the European market. The ...

Medtronic received a CE mark for its Percept neurostimulator to treat symptoms associated with Parkinson’s disease, essential tremor and epilepsy. · MedTech Dive · Courtesy of Medtronic Medtronic ...

Medtronic plc MDT recently announced receipt of the FDA’s approval for its Percept PC Deep Brain Stimulation (“DBS”) system. The inclusion of the BrainSense technology with the Percept PC DBS system ...

The US Food and Drug Administration (FDA) has approved Medtronic's technologically advanced deep brain stimulation (DBS) system designed to more precisely target motor symptoms in Parkinson's disease, ...

GUIDE DBS is the World's First Deep Brain Stimulation Visual Simulation System NATICK, Mass., Boston Scientific Corporation has received CE Mark approval for use of the GUIDE™ DBS System, the world's ...

Newronika has completed a €13.6m ($14.1m) Series B funding to advance the development of AlphaDBS, an adaptive deep brain stimulation (DBS) system for addressing the symptoms of Parkinson’s disease.

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the United States Food and Drug Administration approval and first implant of the ...